MedTrace Logo

Total30 Sphere Contact Lenses

NCT05183022 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2022-12-16

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to map comfort over the full wear day in established, asymptomatic, soft CL wearers who are refit in Total30 Sphere CLs.

Conditions

  • Contact Lens Complication
  • Dry Eye

Interventions

DEVICE

Total30 Sphere Contact Lenses

Participants will be refit into Total30 Sphere contact lenses and followed for 1 month.

Sponsors & Collaborators

  • Alcon Research

    collaborator INDUSTRY

  • University of Alabama at Birmingham

    lead OTHER

Principal Investigators

  • Andrew D Pucker, OD, MS, PhD · University of Alabama at Birmingham

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-01-03
Primary Completion
2022-07-20
Completion
2022-07-20
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05183022 on ClinicalTrials.gov